文献速递瓣膜外科

无症状重度主动脉瓣狭窄:手术与经导管换瓣对比的个体患者数据Meta分析

Surgical vs Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis- an Updated Meta-Analysis of Reconstructed Individual Patient Data.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2026-01-01

该研究通过重建个体患者数据的Meta分析,比较保守治疗与TAVR或SAVR在无症状重度主动脉瓣狭窄中的效果。

要点

  • 无症状重度AS患者行SAVR或TAVR较保守治疗显著降低全因死亡风险(IRR=0.43)。
  • TAVR与SAVR均显示一致的长期生存获益,卒中风险无显著差异。
  • 心衰住院、心源性猝死和心肌梗死风险在瓣膜置换后均显著降低。

核心结论

  • 无症状重度AS患者接受SAVR或TAVR较保守治疗与更低短期和长期死亡率相关。

主要发现

  • 全因死亡风险:AVR组IRR=0.43(95%CI 0.32-0.57,P<.001)。
  • 心血管死亡风险:AVR组IRR=0.47(95%CI 0.29-0.75,P<.01;I2=62%)。
  • 心衰住院风险:AVR组IRR=0.39(95%CI 0.22-0.67,P<.01)。
  • 心源性猝死风险:AVR组IRR=0.13(95%CI 0.04-0.48,P<.01)。
  • 心肌梗死风险:AVR组IRR=0.11(95%CI 0.04-0.31,P=.03);卒中风险IRR=0.77(95%CI 0.58-1.02,P=.07)。

临床怎么用

  • 对于无症状重度AS患者,SAVR或TAVR较保守治疗可显著改善生存并降低心衰住院等不良事件风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The management of asymptomatic aortic stenosis (AS) is controversial. We perform a meta-analysis of reconstructed individual patient data to compare conservative treatment versus transcatheter or surgical aortic valve replacement (TAVR or SAVR) in asymptomatic AS. METHODS: PubMed/MEDLINE, Web of Science, Scopus, and Cochrane CENTRAL were systematically searched, through 25th September 2025, to identify any observational or randomized controlled studies that comply with our inclusion criteria. Our primary outcomes were short cardiovascular and non-cardiovascular mortality as well as long-term mortality. We combined aggregate data meta-analysis for dichotomous outcomes using incidence rate ratio (IRR) with reconstructed time-to-event data derived from published Kaplan-Meier curves using validated algorithms. RESULTS: Seventeen studies were included. Overall, AVR was associated with a significantly lower risk of all-cause mortality compared with conservative management (IRR = 0.43; 95% CI, 0.32-0.57; P < .001). Cardiovascular mortality was also significantly reduced with AVR (IRR = 0.47; 95% CI, 0.29-0.75; P < .01; I2 = 62%). The risk of heart failure hospitalization was markedly lower among AVR recipients (IRR = 0.39; 95% CI, 0.22-0.67; P < .01), with consistent benefit across study designs. AVR was further associated with a substantial reduction in sudden cardiac death (IRR = 0.13; 95% CI, 0.04-0.48; P < .01) and myocardial infarction (IRR = 0.11; 95% CI, 0.04-0.31; P = .03). The risk of stroke was not significantly different between groups (IRR = 0.77; 95% CI, 0.58-1.02; P = .07). Reconstructed Kaplan-Meier analyses demonstrated durable long-term survival benefit with AVR, consistent across surgical and transcatheter approaches. CONCLUSIONS: Patients with asymptomatic AS, managed with either SAVR or TAVR, were associated with lower short- and long-term mortality compared to conservative management.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Awad AK, Badran AS, Gonnah AR, et al. Surgical vs Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis- an Updated Meta-Analysis of Reconstructed Individual Patient Data. Interdiscip Cardiovasc Thorac Surg. 2026. PMID: 41442457. doi:10.1093/icvts/ivaf308

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。